Dr. Swarnalok De receives a one-year grant from the Finnish Cultural Foundation
The Finnish Cultural Foundation has recently awarded significant grants for science and art to individuals and research groups from Aalto University. Among the grantees is Dr. Swarnalok De from the Multifunctional Materials Design research group (School of Chemical Engineering) who received a one-year grant for research on the development of wearable healthcare sensors for autonomous health monitoring of the aging population from the Artturi and Aina Helenius fund.
More information about the awarded research work:
Finland is among the top three countries in the world with the highest percentage of population over 65 years. Supporting healthy aging and maintaining the autonomy and safety of older adults is one of the primary societal goals. However, growing life expectancy poses an increasing burden on the already highly strained health systems. Wearable sensor technology in this context offers immense potential to transform our ability to manage health and independence in aging populations.
The Finnish Cultural Foundation has awarded Dr. Swarnalok De a one-year grant of €34,000 for research on the development of wearable healthcare sensors for autonomous health monitoring of the aging population. He will use a unique biobased nanoparticle produced by a mild plant virus to develop the sensors. These sensors will have a distinct edge over the conventional ones in terms of ease of miniaturization, enhanced sensitivity, autonomous power supply, and sustainability.
Contact information
Read more news
ACRIS service restored
The ACRIS research information management system is now open following the planned service break on 13–20 April 2026.
Science must have a voice in society – but how?
Trust in science has fallen in Finland by almost ten percentage points in two years
Meet our startup: Proteins.1 aims for a breakthrough in early disease detection
Biotechnology startup Proteins.1 is developing a technology that could enable the detection of diseases such as cancer months, or even years, earlier than is currently possible. The key lies in identifying individual proteins from a blood sample.